21 Corresponding authors: 22 k.tuschl@ucl.ac.uk, https://orcid.org/0000-0001-8599-8516 23 emb81@cam.ac.uk, https://orcid.org/0000-0001-6450-744X 24 25 Abbreviated title: slc39a14 deficiency causes Mn dyshomeostasis 26 27 Abstract 30Mutations in SLC39A14, a manganese uptake transporter, lead to a neurodegenerative 31 disorder characterised by accumulation of manganese in the brain and rapidly progressive 32 dystonia-parkinsonism (Hypermanganesemia with Dystonia 2, HMNDYT2). Similar to the 33 human phenotype, zebrafish slc39a14 U801-/mutants show prominent brain manganese 34 accumulation and abnormal locomotor behaviour. In order to identify novel potential targets of 35 manganese neurotoxicity, we performed transcriptome analysis of individual homozygous 36 mutant and sibling slc39a14 U801 zebrafish at five days post fertilisation unexposed and 37 exposed to MnCl2. Anatomical gene enrichment analysis confirmed that differentially 38expressed genes map to the central nervous system and eye. Biological interpretation of 39differentially expressed genes suggests that calcium dyshomeostasis, activation of the 40 unfolded protein response, oxidative stress, mitochondrial dysfunction, lysosomal disruption, 41 apoptosis and autophagy, and interference with proteostasis are key events in manganese 42neurotoxicity. Differential expression of visual phototransduction genes also predicted visual 43 dysfunction in mutant larvae which was confirmed by the absence of visual background 44 adaptation and a diminished optokinetic reflex. Surprisingly, we found a group of differentially 45 expressed genes in mutant larvae that normalised upon MnCl2 treatment suggesting that, in 46 addition to neurotoxicity, manganese deficiency is present either subcellularly or in specific 47 cells or tissues. This may have important implications for treatment as manganese chelation 48 may aggravate neurological symptoms. Our analyses show that slc39a14 U801-/mutant 49 zebrafish present a powerful model to study the cellular and molecular mechanisms underlying 50 disrupted manganese homeostasis. 51 52 Significance statement 53 Manganese neurotoxicity leading to progressive dystonia-parkinsonism is a characteristic 54 feature of Hypermanganesemia with dystonia 2 (HMNDYT2) caused by mutations in 55 SLC39A14, a manganese uptake transporter. Transcriptional profiling in slc39a14 U801 loss-of-56 function zebrafish suggests that, in addition to manganese neurotoxicity, subcellular or cell 57 type specific manganese deficiency contributes to the disease phenotype. Both manganese 58 overload and deficiency appear to be associated with Ca 2+ dyshomeostasis. We further 59 demonstrate that activation of the unfolded protein response, oxidative stress, mitochondrial 60 dysfunction, apoptosis and autophagy, and disrupted proteostasis are likely downstream 61 events in manganese neurotoxicity. Our study shows that the zebrafish slc39a14 U801 loss-of-62 function mutant is a powerful model to elucidate the mechanistic basis of diseases affected by 63 manganese dy...